Page last updated: 2024-10-29

iohexol and Thalassemia

iohexol has been researched along with Thalassemia in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Masrouha, KZ1
Wazen, J1
Haddad, A1
Saadeh, F1
Taher, A1
Khoury, NJ1

Other Studies

1 other study available for iohexol and Thalassemia

ArticleYear
Cortical bone invasion in non-transfusion-dependent thalassemia: tumefactive extramedullary hematopoiesis reviewed.
    La Radiologia medica, 2016, Volume: 121, Issue:8

    Topics: Adolescent; Adult; Child; Contrast Media; Cortical Bone; Female; Hematopoiesis, Extramedullary; Huma

2016